Skip to main content
Premium Trial:

Request an Annual Quote

SGI-DNA: Brian Donnelly

Synthetic biology firm SGI-DNA announced the appointment of Brian Donnelly to the newly created position of chief commercial officer. Donnelly will be responsible for global sales, marketing, customer service and support, and business development.

Donnelly comes to the firm from Illumina, where he most recently led Illumina's global service organization. During his time at Illumina, Brian also led the global commercial strategy and global clinical marketing teams. He has also held commercial and operational roles at Sequenom, GlaxoSmithKline, and Allergan. He holds MBA and JD degrees from Rutgers University.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.